Travere Therapeutics, Inc. - Common Stock —— 现金流量表 (NASDAQ:TVTX) | MetaTrader

展开完整图表完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 -42.74 M-14.79 M-186.29 M-280.02 M-237.47 M37.78 M 39.61 M 投资活动产生的现金 -61.33 M-137.62 M-32.55 M55.78 M99.33 M27.89 M 8.15 M 融资活动产生的现金 127.71 M231.68 M117.57 M218.75 M139.42 M-33.47 M -32.98 M 自由现金流 -42.74 M-14.79 M-186.29 M-280.02 M-237.47 M37.78 M 39.61 M

新闻

Redwire Stock, Comfort Systems, 15 Others Join IBD Watchlists

Dow Jones Leader Amazon, AI Stock Quanta, Monster Beverage In Or Near Buy Zones

AstraZeneca Stock: 8% Q1 Revenue Growth And Imfinzi/Ultomiris Trial Data Wins (NYSE:AZN)

Computer Giant Dell Leads 10 Newcomers To Big Cap 20, Other Best Stock Lists

Travere, IBD Stock Of The Day, Is On Path To $3 Billion And In A Buy Zone

Travere Therapeutics, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:TVTX) 2026-05-07

Nvidia, Amazon, SiTime Among New Names On IBD 50, Stock Spotlight And More

Travere Therapeutics Analysts Increase Their Forecasts Following Q1 Earnings - Travere Therapeutics (NASD

Travere Therapeutics, Inc. (TVTX) Q1 2026 Earnings Call Transcript

Compared to Estimates, Travere (TVTX) Q1 Earnings: A Look at Key Metrics

Travere Therapeutics (TVTX) Reports Q1 Loss, Misses Revenue Estimates

Why This Biotech ETF — The IBD Stock Of The Day — Just Reentered Its Buy Zone